D. E. Shaw & Co. Inc. Takes Position in STERIS plc (NYSE:STE)

D. E. Shaw & Co. Inc. acquired a new position in STERIS plc (NYSE:STE - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 181,178 shares of the medical equipment provider's stock, valued at approximately $37,243,000. D. E. Shaw & Co. Inc. owned approximately 0.18% of STERIS as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of STE. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of STERIS by 30.8% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider's stock worth $2,275,000 after purchasing an additional 2,583 shares during the last quarter. Merit Financial Group LLC purchased a new stake in shares of STERIS during the fourth quarter valued at about $260,000. Blue Trust Inc. boosted its holdings in shares of STERIS by 19.9% in the 4th quarter. Blue Trust Inc. now owns 1,128 shares of the medical equipment provider's stock valued at $232,000 after buying an additional 187 shares in the last quarter. Entropy Technologies LP purchased a new position in shares of STERIS in the 4th quarter worth approximately $924,000. Finally, Park Avenue Securities LLC raised its stake in shares of STERIS by 5.6% during the 4th quarter. Park Avenue Securities LLC now owns 2,369 shares of the medical equipment provider's stock worth $487,000 after acquiring an additional 126 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company's stock.

STERIS Stock Up 0.3 %

STE stock opened at $226.54 on Friday. The company has a market capitalization of $22.26 billion, a P/E ratio of 48.10 and a beta of 0.96. STERIS plc has a 12 month low of $200.98 and a 12 month high of $248.24. The firm's fifty day simple moving average is $223.40 and its 200-day simple moving average is $218.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, equities research analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 26th. Stockholders of record on Tuesday, June 10th will be paid a $0.57 dividend. The ex-dividend date is Tuesday, June 10th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.01%. STERIS's payout ratio is 48.41%.

Analyst Ratings Changes

STE has been the topic of several analyst reports. JMP Securities reaffirmed a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a report on Thursday, April 10th. Needham & Company LLC restated a "hold" rating on shares of STERIS in a research note on Monday, April 7th. Piper Sandler increased their price target on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Finally, Stephens raised shares of STERIS to a "strong-buy" rating in a research report on Thursday, May 1st. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.